IDXX - IDEXX Laboratories Non-GAAP EPS of $2.07 beats by $0.15 revenue of $828.57M beats by $7.66M initiates 2023 guidance
- IDEXX Laboratories press release ( NASDAQ: IDXX ): Q4 Non-GAAP EPS of $2.07 beats by $0.15 .
- Revenue of $828.57M (+3.4% Y/Y) beats by $7.66M .
- FY2023 Outlook: Revenue of $3.595B to $3.69B and consensus of $3.62B; operating margins of 29% to 29.6%; EPS outlook of $9.27 to $9.75 vs. consensus of $9.51.
For further details see:
IDEXX Laboratories Non-GAAP EPS of $2.07 beats by $0.15, revenue of $828.57M beats by $7.66M, initiates 2023 guidance